Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:        
Research and development $ 328 $ 1,219 $ 586 $ 1,916
General and administrative 623 684 1,366 1,261
Loss from operations (951) (1,903) (1,952) (3,177)
Interest income (2) (15) (5) (47)
Net Loss $ (949) $ (1,888) $ (1,947) $ (3,130)
Net loss per common share outstanding, basic and diluted $ (0.06) $ (0.11) $ (0.12) $ (0.19)
Weighted average number of common shares outstanding, basic and diluted 16,556,320 16,474,655 16,556,320 16,474,655